Monthly Archives: April 2015

Biopharmaceutical News Week17

Acquisitions /mergers/joint-ventures April 21, 2015 Teva offers $40 billion to acquire Mylan In our newsweek15 we had indicated that the unsolicited offer of Mylan (UK and The Netherlands) to acquire Perigo (Dublin, Ireland) was a defensive move to avoid an imminent hostile takeover. Tuesday was bad news for Mylan when it got confirmation that Teva […]

read more

Biopharmaceutical News Week16

Acquisitions /mergers/joint-ventures Recro acquires Alkermes’ assets Recro Pharma (Malvern, PA, USA) acquires Alkermes’ (Dublin, Ireland) manufacturing facility in Gainesville (GA, USA). The facility will manufacture several products including Meloxicam iv/im, a proprietary Phase III long acting COX-2 NSAID designed for the treatment of moderate to severe acute pain. Under the terms of the agreement Alkermes […]

read more

Biopharmaceutical News week 15

Acquisitions /mergers/joint-ventures Mylan offers $29 billion to acquire Perrigo Generic company Mylan (now located in Potters Bar, UK) offered almost $29 billion ($205 per-share) to acquire Perrigo (Dublin, Ireland), an over-the –counter drug company, in a cash and stock deal. Perrigo would bring a large number of over-the-counter brand drugs as well as Elan’s acquired […]

read more

Biopharmaceutical News Week 14

Acquisitions /mergers/joint-ventures March 30, 2015 Fujifilm acquires Cellular Dynamics for $307M In recent previous newsweeks we had indicated that Canon and Nikon had entered the biomedical field. We now see that Fujifilm Holdings (Tokyo, Japan) acquires Cellular Dynamics International (CDI, Madison, Wis, USA) in a deal worth $307 million in buying all issued and outstanding […]

read more